Therapeutic Antibodies – Products

Refeyn, has developed and launched a custom software platform providing automated analysis of large mass photometry data sets.

This application note explores how these complementary techniques provide unique insights into size heterogeneity, offering a clearer picture of antibody integrity.

BioPharmaSpec has officially announced three new European facilities. The new facilities will focus on discovery and R&D services, offering structural and physicochemical characterization services for a wide variety of biopharmaceutical products.

Lonza, announced a long-term extension of its collaboration with a major global biopharmaceutical partner for commercial-scale manufacture of ADCs.

Refeyn, announces that it has established a new Scientific Advisory Board, chaired by Justin Benesch, Professor of Biophysical Chemistry, Oxford University and co-founder of Refeyn.

Lonza’s GS Gene Expression System® is a comprehensive toolbox for therapeutic protein expression, supporting the production of various molecules, including monoclonal antibodies, bispecifics, fusion proteins and beyond, with titres up to 9 g/L.

Scientists are constantly innovating newer technologies that allow them to understand nuances within these drugs and find ways to manufacture them more reliably.

As a great partner for pharmaceutical industry, Sino Biological is proud to announce the launch of anti-payload mAbs FREE trial campaign. You can get anti-MMAE/MMAF mAbs freely, just contact us to apply—let's get started. Move now!

Study describes method to successfully modify the functional activity of Spycatcher protein for the rapid generation and high-throughput screening of bispecific antibodies.

Four new anti-idiotypic antibodies and a new anti-MMAE antibody range support bioanalytical assay development for preclinical research and clinical trials.